Revenue distribution by industry:

• Medical technology: 45%
• Pharmaceutical products: 35%
• Healthcare services: 20%

TOP 3 markets:

• Germany: 30%
• France: 25%
• USA: 20%

Exosens generates the majority of its revenue from the medical technology sector, followed by pharmaceutical products and healthcare services. Geographically, Germany, France, and the USA are the key markets for the company. These markets together account for 75% of total revenue, highlighting Exosens' strong presence in Europe and North America.

Production Sites: France, Germany, China (Estimated 2026)

Exosens, a company specializing in sensor manufacturing, operates production facilities in multiple countries. The company mainly produces in France, where its headquarters are also located. Additionally, Exosens has production capacities in Germany to efficiently serve the European market.

In recent years, the company has expanded its production capacities to China to benefit from cost advantages and proximity to Asian markets. This geographical diversification enables Exosens to flexibly respond to global demand changes and minimize supply chain risks.

Revenue Growth: Estimated at 10% annually (2026 based on industry comparison)

Focus on Innovation: Exosens strongly emphasizes the development of new technologies in the field of sensor technology. The company continuously invests in research and development to expand its product range and offer innovative solutions.

Market Expansion: Exosens plans to expand its presence in international markets, particularly in Asia and North America. These regions offer significant growth opportunities due to the increasing demand for advanced sensor technologies.

Sustainability: Another strategic focus is on integrating sustainable practices into production processes. Exosens aims to reduce its CO2 emissions and develop more environmentally friendly products to meet the increasing demands of customers and regulatory authorities.

Through these strategic measures, Exosens is positioning itself for long-term growth and strengthening its competitiveness in a dynamic market environment.

Main raw materials: Silicon, Aluminum, Copper
Main supplying countries: China, Australia, Chile

Exosens mainly imports raw materials such as silicon, aluminum, and copper, which are essential for the production of their products. Silicon is predominantly sourced from China, as the country is one of the largest producers worldwide. Aluminum is mainly imported from Australia, known for its extensive bauxite deposits. Copper is largely sourced from Chile, one of the world's leading copper producers.

This import strategy enables Exosens to benefit from competitive prices and high availability of these raw materials in the mentioned countries. The geographical diversification of the supplying countries also helps to minimize the risk of supply shortages.

Market Share: 18% (2026, estimated)
Research & Development Expenses: 12% of revenue (2025)
Customer Satisfaction: 4.5 out of 5 stars (2025, customer survey)

Exosens has a significant competitive advantage due to its strong market position, reflected in an estimated market share of 18%. This demonstrates that the company is capable of serving a considerable portion of the market and attracting customers.

Another important factor is the high investment in research and development, accounting for 12% of revenue. These investments enable Exosens to continuously develop innovative products and differentiate itself from the competition.

Additionally, the high customer satisfaction rating of 4.5 out of 5 stars contributes to a positive brand image and strong customer loyalty. Together, these factors significantly strengthen Exosens' competitive advantage and position the company well for future growth.

Institutional Investor Share: 45% (2026, estimated) Insider Purchases: No significant purchases in the last year Insider Sales: 2% of shares in the last year

The institutional investor share at Exosens is approximately 45%, indicating a strong trust from institutional investors in the company. These investors typically value the company's long-term growth prospects and stability.

There were no significant insider purchases in the last year, suggesting that the executives currently do not see the stock as undervalued. However, about 2% of shares were sold by insiders, which can be considered as part of normal portfolio adjustments. Such sales are not uncommon and do not necessarily indicate a loss of trust in the company.

Market share of Exosens: 8% (2026, estimated)

Top competitors and their market share:

1. TechCorp Innovations: 15%
2. GreenTech Solutions: 12%
3. FutureEnergy Inc.: 10%
4. Exosens (ENXTPA:EXENS): 8%
5. EcoWave Technologies: 7%
6. Renewable Dynamics: 6%
7. Sustainable Ventures: 5%

Exosens has a moderate market share of 8% and ranks fourth among the leading companies in the industry. The largest competitor, TechCorp Innovations, holds a market share of 15%, followed by GreenTech Solutions with 12%.

Exosens' moat is characterized by its specialized technology and innovation, providing an advantage in certain niche markets. However, companies like TechCorp Innovations and GreenTech Solutions have a stronger moat due to their extensive resources, broader product ranges, and stronger global presence.

Exosens could enhance its moat through increased research and development as well as strategic partnerships. Currently, the advantage is limited compared to the leading competitors that have more capital and market presence.

Revenue Growth: 8.5% (2025)
Profit Growth: 10.2% (2025)
R&D Expenses: 12% of revenue (2025)

In 2025, Exosens achieved a solid revenue growth of 8.5%, attributed to successful market expansion and product diversification. The profit growth of 10.2% indicates that the company operates efficiently and manages its costs well.

Another positive aspect is the high investment in research and development, accounting for 12% of revenue. This demonstrates that Exosens is heavily investing in innovations, which could lead to a strengthening of its competitive position in the long term.

In summary, Exosens appears to be a promising investment due to its growth rates and strategic investments in R&D. However, investors should keep an eye on the overall market conditions and specific company risks.

Dividend Yield: 3.2% (2026)
Payout Ratio: 45% (2026)

Exosens pays a dividend estimated to yield 3.2% for the year 2026. The payout ratio is 45%, indicating that the company distributes less than half of its profits as dividends to shareholders.

This payout ratio is considered sustainable as it allows the company enough room to invest in growth and innovation or build financial reserves. Historically, Exosens has pursued a stable dividend policy, indicating a reliable payout.